Johannes Fruehauf, M.D.
With his background as a physician working in diverse health systems, coupled with 20+ years as a serial biotech entrepreneur, Dr. Fruehauf has dedicated much of his professional endeavors to supporting life science entrepreneurs and start-up companies. Dr. Fruehauf is currently General Partner and co-founder of Mission BioCapital (MBC). In his role at MBC, Johannes sources, diligences, and leads new life-science investment transactions and represents the fund on the board of a number of MBC portfolio companies.
He is also the Founder and President of LabCentral and BioLabs, the largest provider of laboratory co-working space for startups nationwide, currently serving over 300 startups in 8 cities. The companies started within this network now (2019) account for over 20% of all Seed and Series A venture capital invested in life sciences in the US.
Johannes studied medicine in Germany and France, while also conducting field work in Africa (Zimbabwe and Guinea). Thereafter, he practiced medicine (internal medicine and OB/Gyn) for several years in Germany before coming to Boston for a post-doc at Beth Israel Deaconess Medical Center/Harvard Medical School. Johannes graduated from University of Frankfurt and received his doctorate from the University of Heidelberg. He is also the author of over 30 peer reviewed publications and is named inventor on 9 issued patents on drug delivery and RNAi-based therapeutics.